Preparation of nano composite hydrogel and application of nano composite hydrogel in acceleration of healing of diabetic wounds
By constructing nanocomposite hydrogels of oxidized hyaluronic acid, phenylboric acid grafted ε-polylysine and ZIF-8, the problem of insufficient adhesion and mechanical properties of traditional hydrogels in diabetic wounds is solved, and effective response and antioxidant stress in a low pH and high ROS environment is achieved, and wound healing is promoted.
Patent Information
- Application Number
- CN202410056950.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-01-15
- Publication Date
- 2025-07-22
AI Technical Summary
Traditional hydrogels lack tissue adhesion, poor mechanical properties and lack self-healing ability in biomedical applications, and frequent dressing replacement may lead to wound irritation and infection risks. The existing stimulus-responsive hydrogels have limited effect at diabetic wounds.
A nanocomposite hydrogel is developed, consisting of oxidized hyaluronic acid, phenylboronic acid-grafted ε-polylysine and ZIF-8. It responds to a low pH and high ROS environment through dynamic Schiff base, borate ester bonds and coordination bonds, releases zinc ions and chlorogenic acid, regulates macrophage phenotype, relieves oxidative stress, promotes cell proliferation and angiogenesis.
The injectable, adhesion, self-healing and excellent mechanical properties of the hydrogel are achieved, which can effectively respond to and relieve oxidative stress at diabetic wounds, accelerate wound healing, regulate macrophage phenotype through the NF-κB/JAK-STAT signaling pathway, and promote tissue repair.